Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists
US6908931B2 · kind B2 · utility
3Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2004 |
| Grant date | Jun 21, 2005 |
| Priority date | — |
| Expiry date | Apr 8, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses a series of tetrahydroisoquinolines of formula I which are antagonists of the human melatonin MT2 receptor and are useful as chronobiotic and sleep agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.